Skip to main content

Patent Expiry

AYTU: KARBINAL ER: recorded patent 8062667 expiry

March 29, 2029 · CARBINOXAMINE MALEATE. BioSniper AI can trace the company-impact path without requiring you to write the research question.

Event date
March 29, 2029
Company
AYTU BIOPHARMA, INC (AYTU)
Drug
CARBINOXAMINE MALEATE
BioSniper AIPage evidence connected

Prepared research question

What could this event change, and which evidence should be watched next?

Run cited research

Traceable citations · Unknowns marked

Patent Expiry

KARBINAL ER: recorded patent 8062667 expiry

Orange Book application NDA022556, product 001, listed patent 8062667 expiry. Overall loss of exclusivity and current company rights: unknown.FDA source

Drug
CARBINOXAMINE MALEATE